Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study
Abiy Agiro, Ali Greatsinger, Fan Mu, Erin E. Cook, Jingyi Chen, Manasvi Sundar, Angela Zhao, Ellen Colman, Arun Malhotra
Springer Nature ·
2025-06-18
· DOI 10.1007/s12325-025-03254-z
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Abiy Agiro, Ali Greatsinger, Fan Mu, Erin E. Cook, Jingyi Chen, Manasvi Sundar et al. Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study. // Advances in Therapy. – 2025. – DOI: 10.1007/s12325-025-03254-z. – URL: https://doi.org/10.1007/s12325-025-03254-z
Abiy Agiro, Ali Greatsinger, Fan Mu, Erin E. Cook, Jingyi Chen, Manasvi Sundar, Angela Zhao, Ellen Colman, & Arun Malhotra (2025). Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study. Advances in Therapy. https://doi.org/10.1007/s12325-025-03254-z
Abiy Agiro, et al. “Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.” Advances in Therapy, 2025. doi:10.1007/s12325-025-03254-z.
@article{Agiro2025,
title = {Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study},
author = {Agiro, Abiy and Greatsinger, Ali and Mu, Fan and Cook, Erin E. and Chen, Jingyi and Sundar, Manasvi and Zhao, Angela and Colman, Ellen and Malhotra, Arun},
journal = {Advances in Therapy},
year = {2025},
doi = {10.1007/s12325-025-03254-z},
url = {https://doi.org/10.1007/s12325-025-03254-z}
}